FDA Approves Pill Version of Wegovy

Novo Nordisk's semaglutide will soon be available in a daily pill Americans can take for weight loss. The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company's original version of Wegovy is a weekly injection. Both drugs contain the same active ingredient, semaglutide.